52nd week of 2015 patent applcation highlights part 23 |
Patent application number | Title | Published |
20150368332 | METHODS FOR INCREASING IMMUNOGLOBULIN A LEVELS - Methods for increasing immunoglobulin A (IgA) levels in a subject having a deficiency thereof are provided herein by administering to the subject an agent that inhibits CXCL13 activity, such as an anti-CXCL13 or an anti-CXCR5 antibody. Further provided are methods for treating an inflammatory disorder in a subject deficient for IgA by administering to the subject an agent that inhibits CXCL13 activity. | 2015-12-24 |
20150368333 | TNF-ALPHA ANTIGEN-BINDING PROTEINS - The present invention provides antigen binding proteins which bind specifically to TNF-alpha. For example novel variants of anti-TNF antibodies such as adalimumab which show increased binding to the FcRn receptor or increased half life compared to adalimumab. Also provided are compositions comprising the antigen binding proteins and uses of such compositions in treatment of disorders and disease. | 2015-12-24 |
20150368334 | HIGHLY GALACTOSYLATED ANTI-TNF-ALPHA ANTIBODIES AND USES THEREOF - In one aspect, the disclosure relates to highly galactosylated anti-TNF-alpha antibodies and compositions thereof. In one aspect, the disclosure relates to populations of anti-TNF-alpha antibodies with a high level of galactosylation, and compositions thereof. In one aspect, the disclosure relates to methods of production and use of highly galactosylated anti-TNF-alpha antibodies and populations of anti-TNF-alpha antibodies with a high level of galactosylation. In some embodiments, the anti-TNF-alpha antibody is adalimumab. | 2015-12-24 |
20150368335 | TREATMENT OF TNF-ALPHA RELATED DISORDERS - Methods of treating TNFα-related disorders comprising administering TNFα inhibitors, including TNFα antibodies are described. | 2015-12-24 |
20150368336 | IL-31 MONOCLONAL ANTIBODIES - The present invention relates to methods of treating pruritic diseases, including but not limited to Contact dermatitis, Atopic Dermatitis, Drug induced delayed type cutaneous allergic reactions, Toxic epidermal necrolysis, Cutaneous T cell Lymphoma, Bullous pemphigoid, Alopecia wereata, Vitiligo, Acne Rosacea, Prurigo nodularis, Scleroderma, Herpes simplex virus, or combination thereof by administering IL-31 monoclonal antibodies. The invention further provides the hybridomas that generate the monoclonal antibodies. | 2015-12-24 |
20150368337 | ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF ORAL MUCOSITIS - The present invention is directed to therapeutic methods using IL-6 antagonists such as anti-IL-6 antibodies and fragments thereof having binding specificity for IL-6 to prevent or treat mucositis (e.g., oral mucositis) including persons on a treatment regimen with a drug or chemotherapy and/or radiation for cancer (e.g., head and neck cancer) that is associated with increased risk of mucositis, including oral mucositis. | 2015-12-24 |
20150368338 | Interferon Alpha and Omega Antibody Antagonists - The present invention relates to antibodies that broady neutralize interferon-α and interferon-ω, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing. | 2015-12-24 |
20150368339 | MUSCARINIC ACETYLCHOLINE RECEPTOR BINDING AGENTS AND USES THEREOF - Agents that specifically bind to a muscarinic acetylcholine receptor in a conformationally-specific way can be used to induce a conformational change in the receptor. Such agents have therapeutic applications and can be used in X-ray crystallography studies of the receptor. Such agents can also be used to improve drug discovery via compound screening and/or structure based drug design. | 2015-12-24 |
20150368340 | HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR GLYPICAN-3 AND USE THEREOF - Described herein is the identification of human monoclonal antibodies that bind GPC3 or heparan sulfate (HS) chains on GPC3 with high affinity. The antibodies described herein are capable of inhibiting HCC cell growth and migration. Provided are human monoclonal antibodies specific for GPC3 or HS chains on GPC3, including immunoglobulin molecules, such as IgG antibodies, as well as antibody fragments, such as single-domain VH antibodies or single chain variable fragments (scFv). Further provided are compositions including the antibodies that bind GPC3 or HS chains on GPC3, nucleic acid molecules encoding these antibodies, expression vectors comprising the nucleic acids, and isolated host cells that express the nucleic acids. Methods of treating cancer and/or inhibiting tumor growth or metastasis are also provided. Further provided are methods of detecting cancer in a subject and confirming a diagnosis of cancer in a subject. | 2015-12-24 |
20150368341 | POLYPEPTIDES AND ANTIBODIES DERIVED FROM CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND USES THEREOF - Small animal models for assessing immunomodulatory effects of compounds are provided. | 2015-12-24 |
20150368342 | CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF - The present disclosure provides a heterodimeric, conditionally active chimeric antigen receptor (CAR), and a nucleic acid comprising a nucleotide sequence encoding the CAR. The present disclosure provides cells genetically modified to produce the CAR. A CAR of the present disclosure can be used in various methods, which are also provided. | 2015-12-24 |
20150368343 | ANTIBODY CONSTRUCTS FOR CDH19 AND CD3 - The present invention provides to a antibody construct comprising a first human binding domain capable of binding to human CDH19 on the surface of a target cell and a second domain capable of binding to human CD3 on the surface of a T cell. Moreover, the invention relates to a nucleic acid sequence encoding the antibody construct, a vector comprising said nucleic acid sequence and a host cell transformed or transfected with said vector. Furthermore, the invention relates a process for the production of the antibody construct of the invention, a medical use of said antibody construct and a kit comprising said antibody construct. | 2015-12-24 |
20150368344 | MDL-1 LIGAND - The invention provides methods for modulation interactions between MDL-1 and its binding partner, Gal9. Also provided are methods to screen for modulators of MDL-1/Gal9 interaction. | 2015-12-24 |
20150368345 | ANTIBODY VARIANTS HAVING MODIFICATIONS IN THE CONSTANT REGION - The present invention relates to positions in the constant region of antibodies, in particular the CH3 region of lgG4, which affect the strength of CH3-CH3 interactions. Mutations that either stabilize or destabilize this interaction are disclosed. | 2015-12-24 |
20150368346 | ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF - Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed. | 2015-12-24 |
20150368347 | ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF - Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed. | 2015-12-24 |
20150368348 | METHOD OF TREATMENT AND AGENTS USEFUL FOR SAME - The present invention relates generally to a method for the treatment and prophylaxis of inflammatory conditions. The present invention is predicated in part on the identification of cells of the monocyte/macrophage lineage being critical for inflammation and, in particular, chronic inflammation. In accordance with the present invention, it is proposed that the reduction in levels of monocyte/macrophage-type cells and/or a reduction in the production of inflammatory and pro-inflammatory mediators by these cells, especially locally, is effective in reducing inflammatory conditions. The present invention further provides animal models useful for screening for reducing levels of monocyte/macrophage-type cells and/or reducing the production of inflammatory and pro-inflammatory mediators of these cells. | 2015-12-24 |
20150368349 | Anti-GITR Antibodies and Methods of Use Thereof - The present disclosure provides antibodies that specifically bind to human glucocorticoid-induced TNFR family related receptor (GITR) and compositions comprising such antibodies. In a specific aspect, the antibodies specifically bind to human GITR and modulate GITR activity, e.g., enhance, activate or induce GITR activity, utilizing such antibodies. The present disclosure also provides methods for treating disorders, such as cancer and infectious diseases, by administering an antibody that specifically binds to human GITR and modulates GITR activity e.g., enhances, activates or induces GITR activity. | 2015-12-24 |
20150368350 | AGONIST FUSION PROTEIN FOR CD40 AND OX40 AND USES THEREOF - Members of the TNF ligand/TNF receptor superfamily play key roles in a large number of biological events. For instance, members of the TNF ligand/TNF receptor superfamily figure prominently in the complex interplay of positive and negative signals that regulate T cell activation, maintenance of T cell effector function, promotion of maturation of antigen-presenting cells, such as dendritic cells, and the T cell stimulation of APCs. TNF receptors are broadly classified in three groups Receptors in the first group contain a death domain in their cytoplasmic tails. Receptors in the second group contain a TRAF interaction motif in their cytoplasmic tails. The third group of TNF receptors do not contain functional intracellular signaling domains but can act as decoy receptors. | 2015-12-24 |
20150368351 | METHOD FOR THE SELECTION OF ANTIBODIES AGAINST BCMA - An antibody specifically binding to human BCMA, characterized in that the binding of said antibody is not reduced by APRIL and not reduced by BAFF, said antibody does not alter APRIL-dependent NF-κB activation, BAFF-dependent NF-κB activation, and does not alter NF-κB activation without BAFF and APRIL is useful as a therapeutic agent. | 2015-12-24 |
20150368352 | NOVEL MULTISPECIFIC CONSTRUCTS - Provided are novel multispecific antibody constructs and multispecific antibody drug conjugates (ADCs), and methods of using such antibodies and ADCs to treat cancer. IgG-like bispecific antibodies have different binding specificities on each arm of the antibody. They are similar in structure to monospecific IgGs in that they contain two heavy chains with VH, CH1, CH2 and CH3 regions, and two light chains with VL and CL regions. | 2015-12-24 |
20150368353 | Anti-Podoplanin Antibodies and Methods of Use - Recombinant scFv-immunotoxins target tumor cells expressing human podoplanin but not podoplanin-negative or normal cells. The immunotoxins can be used for treatment of malignant glioma patients or any malignant tumor expressing podoplanin. One such immunotoxin comprises a modified | 2015-12-24 |
20150368354 | METHODS FOR REDUCING AGGREGATE CONTENT IN PROTEIN PREPARATIONS - A method of reducing aggregate and product-contaminant complex content in a protein preparation including a desired protein includes (i) contacting the protein preparation with at least one solid surface comprising at least one surface-bound ligand capable of binding a metal, the surface-bound ligand being capable of binding a metal is initially substantially devoid of a metal, the operating conditions are selected to substantially prevent the binding of the desired protein to the at least one solid surface and (ii) separating the protein preparation from the surface-bound ligand, such that when more than one surface-bound ligand is present, each surface-bound ligand is independently either of the same net charge or charge neutral. | 2015-12-24 |
20150368355 | ANTI-DLL3 ANTIBODY - It is intended to disclose an antibody which binds to DLL3 protein. Preferably, the antibody of the present invention recognizes a region from amino acids 216 to 492 in human DLL3 having the amino acid sequence as set forth in SEQ ID NO: 1. The present invention also provides a pharmaceutical composition, for example, an anticancer agent, comprising the antibody of the present invention as an active ingredient. The present invention further discloses a method for diagnosing cancer using the antibody of the present invention and a diagnostic drug for cancer comprising the antibody of the present invention. | 2015-12-24 |
20150368356 | TUMOR SPECIFIC ANTIBODIES AND USES THEREFOR - Provided are isolated antibodies, and fragments and derivatives thereof, which bind to tumor antigens. Also provided are compositions and delivery agents that include the disclosed antibodies and fragments and derivatives thereof; cells that produce the same; methods for producing the same; methods of using the same for detecting, targeting, and/or treating tumors and/or metastatic cells derived therefrom and/or tumor stem cells; and methods for predicting the recurrence of cancer in a subject. | 2015-12-24 |
20150368357 | HIGHLY GALACTOSYLATED ANTI-HER2 ANTIBODIES AND USES THEREOF - In one aspect, the disclosure relates to highly galactosylated anti-HER2 antibodies and compositions thereof. In one aspect, the disclosure relates to populations of anti-HER2 antibodies with a high level of galactosylation, and compositions thereof. In one aspect, the disclosure relates to methods of production and use of highly galactosylated anti-HER2 antibodies and populations of anti-HER2 antibodies with a high level of galactosylation. In some embodiments the anti-HER-2 antibody is trastuzumab. | 2015-12-24 |
20150368358 | KLOTHO BETA - The invention concerns uses of anti-KLβ agents, and detection of KLβ and/or FGF19 and/or FGFR4. | 2015-12-24 |
20150368359 | COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISORDERS - The present invention relates to compositions and methods for treating ophthalmic disorders of humans or animals. The present compositions and methods are highly suitable for intraocular administration into the interior of an eye and provide therapeutic effects to the eye as they are effective in stabilizing, enhancing and/or improving a patient's vision. More specifically, the present invention relates to compositions and methods for treating ophthalmic diseases or disorders with exudative, hemorrhagic and/or inflammatory conditions. Even more specifically, the present invention relates to compositions and methods for treating retinal diseases or disorders, and more specifically ophthalmic diseases or disorders related to impaired retinal vessel permeability and/or integrity. | 2015-12-24 |
20150368360 | MODIFIED T LYMPHOCYTES HAVING IMPROVED SPECIFICITY - Provided herein are modified T lymphocytes comprising chimeric receptors and methods of use thereof. | 2015-12-24 |
20150368361 | ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF - Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed. | 2015-12-24 |
20150368362 | ANTI-HISTONE THERAPY FOR VASCULAR NECROSIS IN SEVERE GLOMERULONEPHRITIS - Severe glomerulonephritis involves cell necrosis as well as NETosis, programmed neutrophil death leading to expulsion of nuclear chromatin and neutrophil extracellular traps (NETs). Histones released by neutrophils undergoing NETosis killed glomerular endothelial cells, podocytes, and parietal epithelial cells. This was prevented by histone-neutralizing agents anti-histone IgG, activated protein C and heparin. Histone toxicity on glomeruli was TLR2/4-dependent. Anti-GBM glomerulonephritis involved NET formation and vascular necrosis. Pre-emptive anti-histone IgG administration significantly reduced all aspects of glomerulonephritis, including vascular necrosis, podocyte loss, albuminuria, cytokine induction, recruitment and activation of glomerular leukocytes and glomerular crescent formation. Subjects with established glomerulonephritis treated with anti-histone IgG, recombinant activated protein C, or heparin all abrogated severe glomerulonephritis suggesting that histone-mediated glomerular pathology is a subsequent, not initial event in necrotizing glomerulonephritis. Neutralizing extracellular histones is therapeutic in severe experimental glomerulonephritis. | 2015-12-24 |
20150368363 | USE OF HUMAN CELLS OF MYELOID LEUKAEMIA ORIGIN FOR EXPRESSION OF ANTIBODIES - The invention relates to a method for producing a protein molecule composition having a defined glycosylation pattern, comprising (a) introducing in a host cell which is an immortalized human blood cell at least one nucleic acid encoding at least a part of said protein; and (b) culturing said host cell under conditions which permit the production of said protein molecule composition; and (c) isolating said protein molecule composition. | 2015-12-24 |
20150368364 | Methods for Biodegradable Derivatization of Cellulosic Surfaces - The present invention describes methods of treating cellulosic materials with a composition that provides increased hydrophobicity to such materials without sacrificing the biodegradability thereof. The methods as disclosed provide for esterification of available hydroxyl groups on cellulosic materials, where such hydroxyl groups are “masked” by bulky organic chains, including that the disclosure provides products made by such methods. The materials thus treated display higher hydrophobicity, barrier function, and mechanical properties, and may be used in any application where such features are desired. | 2015-12-24 |
20150368365 | NOVEL ESTERIFIED CELLULOSE ETHERS OF LOW VISCOSITY AND HIGH MOLECULAR WEIGHT - Esterified cellulose ethers which comprise (i) aliphatic monovalent acyl groups or (ii) groups of the formula —C(O)—R—COOA, wherein R is a divalent aliphatic or aromatic hydrocarbon group and A is hydrogen or a cation, or (iii) a combination of aliphatic monovalent acyl groups and groups of the formula —C(O)—R—COOA, which have a viscosity of up 19 mPa·s, measured as a 10 wt % solution of the esterified cellulose ether in acetone at 20° C., and which have a weight average molecular weight M | 2015-12-24 |
20150368366 | NOVEL ESTERIFIED CELLULOSE ETHERS OF VERY HIGH MOLECULAR WEIGHT - Esterified cellulose ethers which comprise (i) groups of the formula —C(O)—R—COOA or (ii) a combination of aliphatic monovalent acyl groups and groups of the formula —C(O)—R—COOA, wherein R is a divalent aliphatic or aromatic hydrocarbon group and A is hydrogen or a cation, which have a viscosity of up 50 mPa·s, measured as a 10 wt % solution of the esterified cellulose ether in acetone at 20° C., and a weight average molecular weight M | 2015-12-24 |
20150368367 | SURFACE MODIFICATION OF CELLULOSE NANOCRYSTALS - Hydrophobic CNCs were successfully prepared by grafting amine- and thiol terminated hydrocarbons to CNCs that have been previously coated with plant polyphenols. Hydrocarbons of various chain lengths can be used to tune the hydrophobicity of the modified CNCs. After the surface modification process, CNCs can be easily redispersed in nonpolar solvents highlighting the potential of the hydrophobic CNCs in, for example, CNC reinforced nanocomposites and non-aqueous formulations. | 2015-12-24 |
20150368368 | NANOCELLULOSE COMPOSITIONS AND PROCESSES TO PRODUCE SAME - A composition comprising nanocellulose is disclosed, wherein the nanocellulose contains very low or essentially no sulfur content. The nanocellulose may be in the form of cellulose nanocrystals, cellulose nanofibrils, or both. The nanocellulose is characterized by a crystallinity of at least 80%, an onset of thermal decomposition of 300° F. or higher, and a low light transmittance over the range 400-700 nm. Other variations provide a composition comprising lignin-coated hydrophobic nanocellulose, wherein the nanocellulose contains very low or essentially no sulfur content. Some variations provide a composition comprising nanocellulose, wherein the nanocellulose contains about 0.1 wt % equivalent sulfur content, or less, as SO | 2015-12-24 |
20150368369 | Metal Ion-Functional Fiber Component Complex Compositions, Preparation and Uses Thereof - Compositions comprising metal ions or clusters such as ferrous and/or ferric iron compounds or magnesium, zinc, lanthanum and other metal ion compounds and fiber components such as gum Arabic in a complex, methods for preparing such compositions of matter, and the use thereof for treatment of adsorbing certain accessible targets in the gastrointestinal tract and in an extracorporeal system, are provided herein. | 2015-12-24 |
20150368370 | THERMALLY INHIBITED STARCH AND STARCHY FLOURS - The present invention relates to thermally inhibited starch and starchy flours produced by heat treatment of native starch that is pre-dried where necessary to a dry matter content of more than or equal to 95% by weight, preferably 98% by weight, particularly preferably 99% by weight, wherein said starch, pre-dried where necessary, is heat treated in the presence of at least 0.1 percent by volume of oxygen at a product temperature in excess of 100° C. in a vibrating spiral conveyor. | 2015-12-24 |
20150368371 | COAGULATION OF BIOPOLYMERS FROM IONIC LIQUID SOLUTIONS USING CO2 - Disclosed herein are processes for providing a biopolymer from a biomass or source of chitin using ionic liquids. The processes involve contacting a biomass or source of chitin with an ionic liquid to produce a biopolymer comprising solution and precipitating the biopolymer from the solution with supercritical CO | 2015-12-24 |
20150368372 | Cellulosic Arabinoxylan fiber (CAF) And Methods Of Preparing - Processes for the preparation of cellulosic arabinoxylan fiber. Cellulosic arabinoxylan fiber prepared by the processes. Edible formulations, containing the cellulosic arabinoxylan fiber, wherein the cellulosic arabinoxylan fiber functions as bulking agents in the edible formulation. Methods of stabilizing an emulsion, involving mixing an effective stabilizing amount of the cellulosic arabinoxylan fiber with an emulsion to stabilize said emulsion. Methods of increasing the water holding capacity of a composition, involving mixing an effective water holding increasing amount of the cellulosic arabinoxylan fiber with a composition to increase the water holding capacity of said composition. Method of increasing the bulk of a composition, involving mixing an effective bulk increasing amount of the cellulosic arabinoxylan fiber with a composition to increase the water holding capacity of said composition. Methods of increasing the viscosity of a composition, involving mixing an effective viscosity increasing amount of the cellulosic arabinoxylan fiber with a composition to increase the viscosity of said composition. | 2015-12-24 |
20150368373 | TOPICALLY ADMINISTERED, SKIN-PENETRATING GLYCOSAMINOGLYCAN FORMULATIONS SUITABLE FOR USE IN COSMETIC AND PHARMACEUTICAL APPLICATIONS - The present invention relates to topical glycosaminoglycan compositions, particularly hyaluronan compositions, that facilitate the penetration of modified glycosaminoglycans through the skin barrier into the epidermal and dermal layers of the skin, thereby allowing for the dermal administration of a glycosaminoglycan, such as hyaluronan, without requiring an injection. Through their ability to deliver hyaluronan to the epidermal and dermal layers, the present formulations are therefore suitable for use in dermal rejuvenation, enhancement, hyaluronan replenishment and protection therapy. The glycosaminoglycan compositions are also useful as delivery devices to facilitate the dermal and transdermal delivery of cosmetically and pharmaceutically active substances, including pharmaceuticals, polypeptides, proteins and similarly sized biomacromolecules, through the skin barrier. | 2015-12-24 |
20150368374 | CONTINUOUS POLYMERIZATION DEVICE AND METHOD FOR PRODUCING POLYMER COMPOSITION - A continuous polymerization apparatus uses at least a first reactor and a second reactor ( | 2015-12-24 |
20150368375 | Methods For Making Crosslinked Ultra High Molecular Weight Polyethylene - Method of preparing a crosslinked oxidation resistant ultrahigh molecular weight polyethylene polymer (UHMWPE) involves 1) forming a blend containing UHMWPE powder, a crosslinker, and optionally an antioxidant; 2) applying first conditions of pressure and heat to consolidate the UHMWPE and 3) applying second conditions of heat to activate the crosslinker and crosslink the consolidated UHMWPE. The crosslinker activates at high temperature and is peroxide free. | 2015-12-24 |
20150368376 | PRODUCTION METHOD OF POLAR GROUP-CONTAINING OLEFIN POLYMERS - The present invention relates to a method for producing a homopolymer of olefin represented by formula (1): CH | 2015-12-24 |
20150368377 | PREPARATION OF POLYOLEFIN - Catalyst systems and methods for making and using the same are provided. The catalyst systems can include a plurality of silica particles and a metallocene catalyst and an activator supported on the plurality of silica particles. The polymerization catalysts have a particle size distribution in which about 10% of the particles have a size less than about 17 to about 23 micrometers, about 50% of the particles have a size less than about 40 to about 45 micrometers, and about 90% of the particles have a size less than about 72 to about 77 micrometers. | 2015-12-24 |
20150368378 | PLANT OIL-BASED MATERIALS - Plant oil-based compounds are provided which possess both low viscosity and high reactive functionality. These compounds are useful in coating and composite applications, as well as related methods. Exemplary compounds can be produced by transesterification of a plant oil triglyceride with a nucleophile reactant, such as a vinyl-functional alcohol, to yield reactive fatty acid-containing monomers. | 2015-12-24 |
20150368379 | SYNTHESIZING HYPERBRANCHED POLYMERS WITH UNIFORM STRUCTURE IN CONFINED SPACE - Hyperbranched polymers are synthesized with uniform structure based on one pot polymerization technique in confined space with nanometer scale, e.g. micelles in a microemulsion system. The segregated space in micelles or polymerizing nanoparticles is expected to regulate the growth of hyperbranched polymers by confining polymer-polymer reaction inside each individual locus. The obtained hyperbranched polymers have uniform size, similar to the size of nanoparticles, as indicated by a narrow molecular weight distribution of the polymers. | 2015-12-24 |
20150368380 | ANTIMICROBIAL POLYMER - The invention is directed to an antimicrobial polymer that can preferably be processed thermoplastically, a method for the preparation of said antimicrobial polymer and its use in antimicrobial treatment. The invention is further directed to polymer blends containing antimicrobial polymers and the use of special monomers in the preparation of antimicrobial polymers that can be processed thermoplastically. | 2015-12-24 |
20150368381 | PROCESS FOR PREPARING A CATALYST COMPONENT FOR POLYMERIZATION OF OLEFINS - A process for preparing a catalyst component, including: | 2015-12-24 |
20150368382 | POLYMERIZATION CATALYST COMPOSITION, METHOD FOR PRODUCING SYNTHETIC POLYISOPRENE, AND SYNTHETIC POLYISOPRENE - The polymerization catalyst composition includes: Component (A): a rare earth element compound of formula (i): M-(NQ | 2015-12-24 |
20150368383 | ISOPRENE POLYMERIZATION CATALYST COMPOSITION, METHOD FOR PRODUCING SYNTHETIC POLYISOPRENE, AND SYNTHETIC POLYISOPRENE - An isoprene polymerization catalyst composition includes: Component (a): a rare earth element compound having a rare earth element-oxygen bond or a rare earth element-sulfur bond; Component (b): an ionic compound; and Component (c): at least one compound selected from the group consisting of a compound of formula (X): YR | 2015-12-24 |
20150368384 | SILYL GROUP-CONTAINING POLYVINYL ALCOHOL-BASED RESIN AND USE THEREOF - An object of the present invention is to provide a novel silyl group-containing PVA-based resin having excellent adhesiveness to inorganic adherend such as glass, and a short defoam time, and to provide a use of the PVA-based resin. The novel silyl group-containing polyvinyl alcohol-based resin contains a vinyl alcohol unit, 1,2-diol unit in a side chain, and a silyl group-containing unit. An aqueous solution of the silyl group-containing polyvinyl alcohol-based resin is useful for an adhesive because of its excellent defoaming property and superior adhesiveness to inorganic adherend such as glass. | 2015-12-24 |
20150368385 | NOVEL COMB POLYMERS WHICH CAN BE USED IN COSMETICS AND DETERGENTS - A water-soluble copolymer comprising, by mass relative to the total mass of the copolymer:
| 2015-12-24 |
20150368386 | (METH)ACRYLOXY-CONTAINING TRISILOXANE, SILOXANE-CONTAINING POLYMERS AND BIOMEDICAL DEVICES THEREFROM - There is provided a trisiloxane having a 3-(meth)acryloxy-substituted (hydroxylcyclohexyl)ethyl group, useful in making water absorbing silicone-hydrogel films for biomedical devices, such as contact lens, and a process for producing these monomers. This invention also provides for copolymers made from the trisiloxane having a 3-(meth)acryloxy-substituted (hydroxylcyclohexyl)ethyl group described herein. | 2015-12-24 |
20150368387 | METHOD FOR PRODUCING HYDROGENATED CONJUGATED DIENE POLYMER | 2015-12-24 |
20150368388 | PHOTOCURABLE ELASTOMER COMPOSITION, SEAL MATERIAL, GASKET FOR HARD DISC DRIVE, HARD DISC DRIVE AND APPARATUS - A photocurable elastomer composition comprising: (A) a liquid polymer having a number average molecular weight of 5,000 or more, and mainly containing —[CH | 2015-12-24 |
20150368389 | ANTICORROSIVE, TERMINAL-ATTACHED COVERED ELECTRIC WIRE, AND WIRING HARNESS - Provided is an anticorrosive containing a curable resin composition and that has a high anticorrosive capability and a good adhesion to an oily surface, and a terminal-attached covered electric wire and a wiring harness using the anticorrosive. The terminal-attached covered electric wire has a contact portion where a wire conductor of a covered electric wire and a connection terminal contact each other. The contact portion is covered with the anticorrosive. The wiring harness contains the terminal-attached covered electric wire. The curable resin composition contains 100 parts by mass of a polymer of a (meth)acrylate monomer, the polymer having two or more (meth)acrylate groups, 40 to 90 parts by mass of isobornyl (meth)acrylate, and 1 to 15 part by mass of an alkyl (meth)acrylate represented by formula 1, where R1 is either H or CH3, and R2 is an alkyl group having a carbon number of 8 to 13, | 2015-12-24 |
20150368390 | FLUORINE-CONTAINING POLYMER MICROSPHERE - Disclosed in the invention is a fluorine-containing polymer microsphere. A polymerization monomer, a photoinitiator and a stable dispersant are added into a reaction kettle, carbon dioxide gas is introduced for emptying air therein, then liquid carbon dioxide is injected, an initiating light source is used for irradiating in the reaction kettle after the temperature and pressure of the reaction kettle are constant, the reaction is performed under the conditions of −20-30° C. and 20-70 bar, wherein the concentration of the polymerization monomer accounting for the total volume of the reactants is 0.02-2 g/ml, and the weight ratio of the photoinitiator, stable dispersant and polymerization monomer is (0.3-10):(2-20):100; after the reaction is finished, the temperature returns to room temperature, and the precipitate is washed with liquid carbon dioxide, so as to obtain the polymer microspheres. The fluorine-containing polymer which covers the surface of the microspheres in the present invention can reduce the surface energy thereof, and can benefit the timely migration of the microspheres to the coating surface; a tertiary amine group is introduced into the fluorine-containing polymer to firmly bond the microspheres into a cross-linked network, and thus benefits the tight integration of the microspheres and the coating; a RAFT active group is introduced to firmly anchor the microspheres onto the coating film; thus ensuring the stability of the cured coating. | 2015-12-24 |
20150368391 | IMPROVED POWDERED THERMOPLASTIC POLYOLEFIN ELASTOMER COMPOSITION FOR SLUSH MOLDING - The present invention relates to a thermoplastic polyolefin elastomer composition in powder form comprising an olefin block copolymer and optionally a high density polyethylene (HDPE), said composition having a Shore A hardness greater than 75, a Tg less than −45° C., a distinct melting peak greater than 95° C., a zero shear viscosity equal to or less than 1,200 Pa-s and a particle size distribution wherein 85 percent of the particles fall between 150 microns to 420 microns and no particles are greater than 500 microns. Said composition demonstrates good pulverizing and flow characteristics at a temperature of 5° C. or less than the distinct melting peak of the olefin block copolymer. In another aspect, this invention relates to a process for preparing said thermoplastic polyolefin elastomer powder and applications for using said powder. In a further aspect, this invention relates to slush molding or rotational molding said thermoplastic polyolefin elastomer composition into skins, for example skins for automotive interior applications, sporting good applications, housing and building applications, packaging materials, covering materials, toys, hollow parts, and the like. | 2015-12-24 |
20150368392 | CLEAR HYDROPHOBIC TPU - A clear hydrophobic TPU is provided by reacting (a) a hydrophobic polyol made from dimerised fatty acid, (b) a chain extender mixture of a linear diol chain extender and a branched diol chain extender, and (c) a diisocyanate. The preferred polyol is a C | 2015-12-24 |
20150368393 | PROCESS FOR THE EXTRACTION OF POLYHYDROXYALKANOATES FROM BIOMASS - An industrial scale batch or semi-continuous batch PHA extraction process wherein the process operating conditions and control may be quantitatively tuned to batch-to-batch variations based on a practical bench scale assessment but more preferably by means of a calibrated chemometric assessment of the biomass quality. Tuning involves the selection of biomass loading conditions that are commensurate with process solvent and PHA type. Batch operating times and temperatures are matched to modelled and monitored extraction kinetics. PHA-rich solvent gelation is exploited by controlling PHA-rich solvent gel formation. In combination a process Is disclosed that permits for robust and consistent recovered product quality control while at the same time enabling to improve overall process economics. | 2015-12-24 |
20150368394 | CATALYSTS AND METHODS FOR POLYESTER PRODUCTION - Disclosed are polymerization systems and methods for the formation of polyesters from epoxides and carbon monoxide. The inventive polymerization systems feature the combination of metal carbonyl compounds and polymerization initiators and are characterized in that the molar ratios of metal carbonyl compound, polymerization initiators and provided epoxides are present in certain ratios. | 2015-12-24 |
20150368395 | MODIFIED POLYESTERS AND PROCESSES FOR MANUFACTURING THE SAME - Disclosed herein are processes for manufacturing modified polyesters. An esterification reaction of diacid, diol and a branching agent having at least three carboxyl groups is carried out at a temperature of about 180 to 300° C. and a pressure of about 1 to 4 bar to obtain a product of esterification. A polycondensation reaction of the product of esterification and a diamine is carried out at a pressure below about 0.01 bars to obtain the modified polyester. | 2015-12-24 |
20150368396 | FUNCTIONALIZED POLYOXYMETHYLENE BLOCK COPOLYMERS - The invention relates to a method for producing functionalized polyoxymethylene block copolymers comprising the step of polymerizing formaldehyde in a reaction vessel in the presence of a catalyst, the polymerization of formaldehyde in addition taking place in the presence of a starter compound comprising at least 2 Zerewitinoff active H atoms, to obtain an intermediate product. The intermediate product obtained is subsequently reacted with a cyclic carboxylic acid ester or carbonic acid ester, thus obtaining a functionalized polyoxymethylene block copolymer. The invention further relates to functionalized polyoxymethylene block copolymers obtained by such a method and to the use of said copolymers. | 2015-12-24 |
20150368397 | EPOXY AND ALKOXY SILYL GROUP-CONTAINING SILSESQUIOXANE AND COMPOSITION THEREOF - A silicon compound is described, being obtained by a hydrosilylation reaction of the following compound (a), compound (b) and compound (c). Compound (a) is a silsesquioxane derivative having two or more SiH in one molecule. Compound (b) is a compound having, in one molecule, epoxy and/or oxetanyl and an alkenyl having a carbon number of 2 to 18. Compound (c) is a compound having, in one molecule, an alkoxysilyl and an alkenyl having a carbon number of 2 to 18. | 2015-12-24 |
20150368398 | COMPOSITE COMPRISING A MATRIX MATERIAL MADE OF AN AMORPHOUS POLYAMIDE AND USE THEREOF - The invention relates to a composite which comprises a matrix material made of an amorphous polyamide with a glass transition temperature of at least 180° C. The composites according to the invention are used for the production of reinforced components in the fields of sport, leisure, engineering industry, electronics, construction, medical technology, communication and transport means and aeronautical and aerospace engineering. | 2015-12-24 |
20150368399 | PA-MXDT/ZT COPOLYMERS - The invention related to a process for the production of a PA-MXDT/ZT polyamide copolymer comprising the following steps: •i. providing a solid MXDT/ZT salt, wherein MXD is meta-xylylenediamine, T is terephthalic acid, Z is a linear aliphatic diamine having from 2 to 12 carbon atoms and wherein amount of Z is from 5 to 40 mole % with respect to the total amount of MXD and Z units in the copolymer and wherein the MXDT/ZT salt is provided by dosing of liquid diamines MXD and Z to a powder of terephthalic acid; •ii. heating the solid MXDT/ZT salt to a first condensation temperature (Tc1) thereby condensing the salt in solid state to produce a solid polyamide copolymer, wherein Tc1 is below the melting temperature (Tm-salt) of said salt. The invention further relates to a PA-MXDT/ZT polyamide copolymer, wherein MXD is meta-xylylenediamine, T is terephthalic acid, Z is a linear aliphatic diamine having from 2 to 12 carbon atom, Z is from 5 to 40 mole % with respect to the total of MXD and Z units in the copolymer. | 2015-12-24 |
20150368400 | PROCESS FOR THE PRODUCTION OF POLYAMIDES - The invention relates to process for the production of a PA-MXDT/ZT polyamide comprising the following steps: (i) providing a solid MXDT/ZT salt, wherein MXD is meta-xylylenediamine, T is terephthalic acid, Z is a linear aliphatic diamine having from 2 to 12 carbon atoms and wherein the amount of Z is from 0 to 40 mole % with respect to the total of the amount of MXD and Z units in the polymer, (ii) solid state polymerizing the MXDT/ZT salt to obtain the polyamide, wherein the solid state polymerization is carried out at least partly under a diamine atmosphere. The invention further relates to a PA-MXDT/ZT polyamide, wherein the polymer has a glass transition temperature fulfilling the following relation: Tg>226−475*Y, wherein Y is the weight ratio g/g of all CH | 2015-12-24 |
20150368401 | BLOCK COPOLYMERS FOR STABLE MICELLES - The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications. | 2015-12-24 |
20150368402 | ALKOXYSILANE-MODIFIED POLYAMIC ACID SOLUTION, LAMINATE AND FLEXIBLE DEVICE EACH PRODUCED USING SAME, AND METHOD FOR PRODUCING LAMINATE - The present invention provides (A) a polyamic acid solution which can be (i) used to form a film that does not peel off even in a case where the film has a large thickness, and (ii) stably stored at a room temperature, and (B) a laminate that can be suitably used for production of a flexible device. An alkoxysilane-modified polyamic acid solution of the present invention can be obtained by reacting (a) an alkoxysilane compound containing the amino group and (b) a polyamic acid solution, and has a molar ratio of 0.980 or more and 0.9995 or less, which molar ratio is obtained by dividing a total number of moles of an aromatic tetracarboxylic dianhydride by a total number of moles of an aromatic diamine. | 2015-12-24 |
20150368403 | THERMALLY-ACTIVATED SELF-IMMOLATIVE MATERIALS - A polymer including a self-immolative polymer segment and a thermally-activated trigger moiety is described. The self-immolative polymer segment includes a head end, a tail end, and a plurality of repeating units. The trigger moiety includes a cycloaddition adduct that is covalently coupled to the head end of the self-immolative polymer segment. When the polymer is exposed to an activation temperature, the cycloaddition adduct undergoes retro-cycloaddition to release the self-immolative polymer segment. The self-immolative polymer segment then decomposes to sequentially release repeating units in a head-to-tail direction. | 2015-12-24 |
20150368404 | WATER SOLUBLE SILICONE MATERIAL - A water soluble silicone macromer comprising a siloxane backbone having grafted thereto a suitable number of hydrophilic groups to render the macromer water soluble, the macromer comprising a polymerizable functional group grafted to the siloxane backbone. In one aspect, the present invention provides a water soluble silicone macromer having a structure of Formula (1): where M is a hydrophilic group or segment; L is a hydrophilic or hydrophobic linkage; N is a hydrophilic or hydrophobic group or segment. Q is a polymerizable functional group; x is zero or an integer greater than zero; y is zero or an integer greater than zero; v is zero or an integer greater than zero; and z is greater than zero, with the proviso that both y and v are not zero. | 2015-12-24 |
20150368405 | DUROMER, PRODUCTION METHOD, USE AND COMPOSITIONS - A duromer, a method for producing the duromer, a use of the duromer as well as a flame retardant containing the duromer and plastics compositions thereof are disclosed. A phosphorous-containing polymer which is based on multi-functional esters of unsaturated carboxylic acids is three-dimensionally cross-linked and forms the claimed duromer as described. The duromer is suitable as a flame retardant and suitable for use in flame retardants for plastics. | 2015-12-24 |
20150368406 | BIODEGRADABLE AND BIOCOMPATIBLE SHAPE MEMORY POLYMERS - This invention relates to shape memory block copolymers comprising: at least one switching segment having a T | 2015-12-24 |
20150368407 | NESTED SUPRAMOLECULAR CAPSULES - A nested capsule having a first capsule held within a second capsule. Each of the first and second capsules has a shell that is a supramolecular cross-linked network, such as a cucurbituril supramolecular cross-linked network. Each capsule shell is obtained or is obtainable from the complexation of a composition including a host, such as cucurbituril, and one or more building blocks having suitable guest functionality for the host, thereby to form a supramolecular cross-linked network. The nested capsules are suitable for delivering and selectively releasing an encapsulant at a location. | 2015-12-24 |
20150368408 | CELLULOSE HYDROGEL COMPOSITIONS AND CONTACT LENSES FOR CORNEAL APPLICATIONS - The present invention provides cellulose hydrogels having one or more of the following properties: high water content, high transparency, high oxygen permeability, high biocompatibility, high tensile strength and desirable thermal stability. The present invention further provides a process for preparing a cellulose hydrogel comprising (i) a step of activating cellulose, in which the activating step comprises contacting the cellulose with a solvent to activate the cellulose for a time duration from about 2 hours to about 30 hours; (ii) substantially dissolving the activated cellulose to form a solution; and (iii) gelling the solution to form a gel, in which the gelling step comprises allowing the solution to gel in an environment comprising a relative humidity from about 30% to about 80% at 35° C. | 2015-12-24 |
20150368409 | METHOD FOR PRODUCING POLYMER POWDERS THAT CAN BE EASILY REDISPERSED IN WATER - The present invention relates to a process for the preparation of a readily water-redispersible polymer powder by spray drying of an aqueous polymer B dispersion, wherein the spray drying of the aqueous polymer B dispersion is effected in the presence of a polymer A, wherein polymer A has a glass transition temperature ≧60° C., a weight average molecular weight Mw≧1000 and ≦25000 g/mol, a polydispersity index ≦5 and is composed of ≧5 and ≦50 wt % of at least one α,β-monoethylenically un-saturated mono- or dicarboxylic acid and/or anhydride (monomer A1), and ≧50 and ≦95 wt % of at least one other ethylenically un-saturated compound which is copolymerizable with the monomers A1 (monomer A2), in polymerized form, wherein the monomer amounts A1 and A2 sum up to 100 wt %. | 2015-12-24 |
20150368410 | METHOD OF PREPARING FIBER-REINFORCED POLYMER COMPOSITES AND FIBER-REINFORCED POLYMER COMPOSITES PREPARED THEREOF - A method of preparing a fiber-reinforced polymer composite is provided. The method includes (a) providing a swollen clay material; (b) chemically modifying a surface of the swollen clay material with an organosilane to form a silane-modified clay material; (c) intercalating the silane-modified clay material with a binder to form an intercalated clay material; and (d) melt compounding the intercalated clay material with a mixture comprising a polymer and fiber to form the fiber-reinforced polymer composite. A fiber-reinforced polymer composite is also provided. | 2015-12-24 |
20150368411 | POLYMERS, SUBSTRATES, METHODS FOR MAKING SUCH, AND DEVICES COMPRISING THE SAME - The present invention relates generally to substrates for making polymers and methods for making polymers. The present invention also relates generally to polymers and devices comprising the same. | 2015-12-24 |
20150368412 | FILM COMPOSITION - A film formed from a polyethylene composition is disclosed, the polyethylene having a density of 948-956 kg/m | 2015-12-24 |
20150368413 | HIGH DIELECTRIC FILM - The present invention aims to provide a film having a high dielectric constant and a low dissipation factor. The high dielectric film of the present invention includes a vinylidene fluoride/tetrafluoroethylene copolymer (A) with a mole ratio (vinylidene fluoride)/(tetrafluoroethylene) of 95/5 to 80/20. The film includes an β-crystal structure and a β-crystal structure. The ratio of the β-crystal structure is 50% or more. | 2015-12-24 |
20150368414 | ACRYLIC RESIN FILM, AND LAMINATE AND SOLAR CELL MODULE EACH OF WHICH USES SAME - An acrylic resin film which contains a polymer (A1) that is obtained by polymerizing a monomer component that contains 10-100% by mass of i-butyl methacrylate is described, where the acrylic resin film has excellent light transmittance, while exhibiting excellent adhesion to a polyolefin resin. A solar cell module which uses the acrylic resin film is also described. | 2015-12-24 |
20150368415 | Polyethylene Films and Method of Making Same - The present invention is directed to polyethylene films having improved properties. Particularly, relatively thick films having improved tear properties and methods of improving tear, and multilayer films having improved dart impact strength and methods of improving the Dart impact strength. | 2015-12-24 |
20150368416 | Plexifilamentary Sheets - A sheet having a plexifilamentary structure with a normalized Frazier air permeability of between 0.002 and 0.2 (m | 2015-12-24 |
20150368417 | SILK-BASED NANOIMPRINTING - Protein-protein imprinting of silk fibroin is introduced as a rapid, high-fidelity, and/or high-throughput method for the fabrication of nanoscale structures in silk films, through controlled manipulation of heat and/or pressure. High resolution imprinting on conformal surfaces is also demonstrated. | 2015-12-24 |
20150368418 | SILICONE-COATED RELEASE FILM WITH A SPECIAL VACUUM DEEP DRAWING CAPABILITY - Siliconized release film for the production of polymer moldings from fiber composites using a mold, which comprises a support film which is capable of vacuum deep drawing at room temperature and a coating which can be applied in liquid form and consists, optionally after removal of any solvent, of more than 90 atom % of silicon, carbon and/or oxygen, more than 45 atom % of carbon and more than 20 atom % of silicon, in each case based on the total coating and measured by XPS, characterized in that the coating has been crosslinked by means of condensation reactions, addition reactions or radiation. | 2015-12-24 |
20150368419 | Refresh Agent - A coated rubber composition includes a rubber composition coated with a liquid refresh agent selected from the group consisting of one or more liquid terpenes, limonene, carvone, pinene, pine needle oil, citral, orange oil, C9-C15 aliphatics, C9-C15 cycloaliphatics, ethyl lactate, dipentene, 1,8-cineole, eucalyptol, citronellol, geraniol, citronellene, terpinen-4-ol, and combinations thereof. A method of application and a coated rubber composition are also disclosed. | 2015-12-24 |
20150368420 | AMINES SUITABLE FOR USE IN THE MANUFACTURE OF POLYURETHANES - The present invention relates to the use of nitrogenous compounds of formula (I) or of corresponding quaternized, or protonated compounds, for producing polyurethanes, to compositions containing these compounds and also to polyurethane systems obtained using the compounds. | 2015-12-24 |
20150368421 | SUPPORT SHEET FOR DECORATIVE PANEL - A carrier plate for a decorative panel comprising a partly foamed plastic plate on the basis of a filler-admixed polyolefin as a carrier plate for the production of a decorative panel, a method for producing such a plate and its use as a support plate in a decorative panel. | 2015-12-24 |
20150368422 | REVERSIBLY CROSS-LINKABLE RESIN - Reversibly cross-linkable foam is provided. The reversibly cross-linked foam includes a first polymeric material, at least one reversibly cross-linkable monomer polymerized with the first polymeric material, and at least one blowing agent. The reversibly cross-linkable co-polymeric foam is thermally stable at temperatures of at least 10 degrees higher than otherwise identical polymeric foam that does not include the reversibly cross-linkable agent polymerized with the first polymeric material. | 2015-12-24 |
20150368423 | THERMALLY EXPANDING MICROCAPSULES - The present invention provides a thermally expandable microcapsule that has a high expansion ratio and durability at high temperatures, and is not likely to cause discoloration and odor when used for foam molding. The thermally expandable microcapsule of the present invention includes: a shell formed from a polymer; and a volatile expansion agent as a core agent encapsulated by the shell, the shell obtained by polymerizing a monomer composition that contains a nitrile monomer and a compound having a glycidyl group in a molecule, the shell exhibiting a value y of 50% or higher and a ratio y/x of 1.1 or higher, in which x represents a gel fraction at ordinary temperature, and y represents a gel fraction upon heating at 180° C. for 30 minutes. | 2015-12-24 |
20150368424 | NANOSPIKE HYBRID CARBON BLACK - A nanospike hybrid carbon black product includes a plurality of carbon black aggregates. Each of the carbon black aggregates has a surface with a plurality of carbon nanospike formed thereon. The carbon nanospikes may each have a length between about 5 nm and 100 nm, and a width between about 5 nm and about 50 nm. A method for manufacturing the nanospike hybrid carbon black product includes the steps of injecting a primary carbon feedstock into a carbon black reactor, and combusting the carbon feedstock under a predetermined high temperature in the carbon black reactor to form carbon black aggregates. A catalyst is then deposited on surfaces of the carbon black aggregates. A secondary carbon feedstock is injected into the carbon black reactor, and reacted with the catalyst to grow carbon nanospikes on the surfaces of the carbon black aggregates. | 2015-12-24 |
20150368425 | DISPERSANTS - A composition comprising at least one particulate inorganic or organic compound, and a dispersant, said dispersant comprising a residue of a dimer fatty acid and/or trimer fatty acid having at least one carboxylic acid group derivatised to provide a terminal secondary or tertiary amine. The dispersant may be formed by reaction of a dimer fatty acid and/or trimer fatty acid and a secondary or tertiary amine comprising compound. The invention also includes the use of the dispersant for dispersing a particulate inorganic or organic compound in a composition. | 2015-12-24 |
20150368426 | RUBBER COMPOSITION AND PNEUMATIC TIRE HAVING TREAD MANUFACTURED FROM SAID RUBBER COMPOSITION - Provided are a rubber composition having a good balance of improved fuel efficiency, abrasion resistance, and wet grip performance while providing good processability, and a pneumatic tire having a tread manufactured from the rubber composition. A rubber composition comprising: a copolymer synthesized by copolymerization of a conjugated diene monomer and an unsaturated acyclic monoester represented by the formula (1) below; and carbon black and/or silica, | 2015-12-24 |
20150368427 | A Composition, Connector, Process for Improving Bonding Between Two or More Means for Conveying Fluids, and System for Conveying Fluids - A composition comprising: (a) a thermoplastic polymer; (b) a plurality of particles, each said particle having core-shell structure and comprising, (i) a core comprising one or more magnetic materials and (ii) a shell comprising silicon dioxide; wherein the composition comprises particles (b) in an amount from 2 to 15 wt % is provided. Further provided is a connector comprising the composition, a system comprising the connector and a process for improving bonding between two or more means for conveying fluids. | 2015-12-24 |
20150368428 | Use of a polycarboxylic acid in the production of an elastomer composition - The invention relates to the use of a polycarboxylic acid in the preparation of an elastomer composition comprising a precipitated silica as reinforcing inorganic filler and an elastomer, in which said polycarboxylic acid and said precipitated silica are incorporated, independently of each other, into an elastomer. | 2015-12-24 |
20150368429 | POLYESTER MODIFIER COMPOSITION FOR CELLULOSE ESTER RESIN, CELLULOSE ESTER OPTICAL FILM, AND POLARIZING PLATE PROTECTIVE FILM - There is provided a polyester modifier composition for a cellulose ester resin, including: a polyester resin produced by a reaction between a diol and 1,2-dicarboxycyclohexane. The modifier composition has a number-average molecular weight (Mn) in the range of 350 to 2,000 as measured by gel permeation chromatography (GPC). The polyester resin has a molecular weight of less than 350 constitutes 5% or less by mass of the modifier composition. | 2015-12-24 |
20150368430 | THERMALLY STABILIZED POLYARYLENE COMPOSITIONS - A polyarylene composition containing one or more polyarylenes and one or more sterically hindered phenolic stabilizers. The polyarylene composition has enhanced resistance to discoloration and degradation under thermal stress. | 2015-12-24 |
20150368431 | EPOXIDIZED-FATTY-ACID-ALKYL-ESTER PLASTICIZERS FROM NATURAL-OIL SOAP STOCK AND METHODS FOR MAKING SUCH EPOXIDIZED-FATTY-ACID-ALKYL-ESTER PLASTICIZERS - Epoxidized fatty acid alkyl esters produced, at least in part, from a natural-oil soap stock and methods for making such epoxidized fatty acid alkyl esters. Epoxidized fatty acid alkyl esters can be employed in plasticizer compositions in combination with at least one epoxidized natural oil. Such plasticizers can be employed in preparing polymeric compositions comprising a polymeric resin, such as polyvinyl chloride, and the plasticizer. Such polymeric compositions can, in turn, be employed in making various articles of manufacture, such as coatings or jackets for wires and cables. | 2015-12-24 |